This story is about the microbial theory of Alzheimer’s disease. Why am I writing about it? I am writing about it because it’s like unraveling a detective plot. There is a disease that they say a lot of people have — and that is caused, they say, by amyloid deposits in the brain. But then… Read More »
The U.S. Food and Drug Administration granted fast track designation to UB-311, a vaccine for Alzheimer’s disease made by biotechnology company Vaxxinity.1 The shot is an anti-amyloid beta immunotherapeutic vaccine that reportedly treats Alzheimer’s disease by targeting aggregated amyloid beta in the brain.2 Aside from the potential problems that can arise when a vaccine is… Read More »
More evidence has been uncovered that Alzheimer’s disease may actually be a third form of diabetes, according to researchers from Northwestern University. Insulin and insulin receptors in your brain are crucial for learning and memory, and it’s known that these components are lower in people with Alzheimer’s disease. In your brain, insulin binds to an… Read More »
Researchers have used a genetic engineering strategy to dramatically reduce levels of tau — a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer’s disease — in an animal model of the condition. The results, which come from investigators at Harvard-affiliated Massachusetts General Hospital (MGH) and Sangamo Therapeutics Inc., could… Read More »